Aliskiren promotes atrial fibrillation in an experimental whole-heart model

被引：0
|
作者：
Ellermann, C. [1 ]
Mittelstedt, A. [1 ]
Eckardt, L. [1 ]
Frommeyer, G. [1 ]
机构：
[1] Univ Hosp Munster, Dept Cardiovasc Med, Div Electrophysiol, Munster, Germany
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2871
引用
收藏
页码：601 / 602
页数：2
相关论文
共 50 条
  • [1] Propofol suppresses atrial fibrillation in an experimental whole-heart model
    Ellermann, C.
    Koenemann, H.
    Wolfes, J.
    Eckardt, L.
    Frommeyer, G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1195 - 1195
  • [2] Dapagliflozin but not empagliflozin prevents atrial fibrillation in an experimental whole-heart model
    Frommeyer, G.
    Uphoff, J.
    Wolfes, J.
    Eckardt, L.
    Ellermann, C.
    EUROPEAN HEART JOURNAL, 2022, 43 : 505 - 505
  • [3] Action Potential Triangulation Explains Acute Proarrhythmic Effect of Aliskiren in a Whole-Heart Model of Atrial Fibrillation
    Ellermann, Christian
    Mittelstedt, Andre
    Wolfes, Julian
    Willy, Kevin
    Leitz, Patrick
    Reinke, Florian
    Eckardt, Lars
    Frommeyer, Gerrit
    CARDIOVASCULAR TOXICOLOGY, 2020, 20 (01) : 49 - 57
  • [4] Action Potential Triangulation Explains Acute Proarrhythmic Effect of Aliskiren in a Whole-Heart Model of Atrial Fibrillation
    Christian Ellermann
    André Mittelstedt
    Julian Wolfes
    Kevin Willy
    Patrick Leitz
    Florian Reinke
    Lars Eckardt
    Gerrit Frommeyer
    Cardiovascular Toxicology, 2020, 20 : 49 - 57
  • [5] Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart model
    Frommeyer, Gerrit
    Kohnke, Anja
    Ellermann, Christian
    Dechering, Dirk G.
    Kochhaeuser, Simon
    Reinke, Florian
    Fehr, Michael
    Eckardt, Lars
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 236 : 423 - 426
  • [6] Ranolazine reduces levosimendan-mediated atrial fibrillation in an experimental whole-heart model
    Frommeyer, G.
    Ellermann, C.
    Kohnke, A.
    Eckardt, L.
    EUROPEAN HEART JOURNAL, 2018, 39 : 601 - 601
  • [7] The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model
    Frommeyer, Gerrit
    Mittelstedt, Andre
    Wolfes, Julian
    Ellermann, Christian
    Kochhaeuser, Simon
    Leitz, Patrick
    Dechering, Dirk G.
    Eckardt, Lars
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 (11) : 1155 - 1161
  • [8] The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model
    Gerrit Frommeyer
    André Mittelstedt
    Julian Wolfes
    Christian Ellermann
    Simon Kochhäuser
    Patrick Leitz
    Dirk G. Dechering
    Lars Eckardt
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, 390 : 1155 - 1161
  • [9] Ranolazine amplifies the antiarrhythmic effect of amiodarone and dronedarone in an experimental whole-heart model of atrial fibrillation
    Frommeyer, G.
    Kaese, S.
    Uphaus, T.
    Pott, C.
    Eckardt, L.
    Milberg, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 362 - 362
  • [10] Antiarrhythmic Effect of Ranolazine in Combination with Class III Drugs in an Experimental Whole-Heart Model of Atrial Fibrillation
    Frommeyer, Gerrit
    Milberg, Peter
    Uphaus, Timo
    Kaiser, Dennis
    Kaese, Sven
    Breithardt, Guenter
    Eckardt, Lars
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (06) : E63 - E71
12345